HealthEquity, Inc.
HQY
Positions held
Your positionsHQY isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- HealthEquity, Inc. operates in a growing healthcare sector, focusing on health information services, which are increasingly vital as healthcare systems evolve.
- In 2026, HealthEquity reported a revenue of $1.31 billion, reflecting a 9.5% increase from the previous year.
- The company's net income for 2026 reached $215.201 million, showcasing a significant growth compared to $96.703 million in 2025.
- Despite growth, HealthEquity's trailing P/E ratio of 32.87 suggests that the stock may be overvalued compared to its earnings.
- The revenue decreased by 1% in the last quarter, dropping from $355 million to $351 million.
- The company's operating margin has shown a decline from 29.34% in Q2 2026 to 28.42% in Q3 2026.
Fundamentals
| Market cap | $7.70B | Enterprise value | $8.41B | Trailing P/E | 33.59 | Forward P/E | 16.92 |
| PEG | 1.13 | Price / book | 3.88 | Beta | 0.24 | Dividend yield | 0.00% |
| Revenue growth | 7.6% | Earnings growth | 14.7% | Gross margin | 71.2% | Operating margin | 28.4% |
| Profit margin | 17.4% | ROE | 11.4% | ROA | 6.7% | Debt / equity | 0.49 |
| Current ratio | 2.99 | Free cash flow | $397.51M | Analyst recommendation | strong_buy | Mean target | $119.33 |
| 52w high | $107.62 | 52w low | $72.76 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | |
|---|---|---|---|---|---|
| Revenue | $351M | $355M | $335M | $322M | $326M |
| Op margin | 28.4% | 29.3% | 21.6% | 24.8% | 27.9% |
| Net income | $65.6M | $69.4M | $49.7M | $51.7M | $59.9M |
| Gross margin | 73.5% | 72.3% | 68.2% | 70.8% | 71.4% |
| Gross profit | $258M | $256M | $228M | $228M | $233M |
| Operating income | $99.7M | $104M | $72.4M | $79.9M | $90.9M |
- Revenue -1% vs prior quarter ($351M vs $355M).
- Gross margin 73.5% (was 72.3% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1000M | $862M | — |
| Op margin | 24.9% | 16.9% | 12.8% | 4.4% | — |
| Net income | $215M | $96.7M | $55.7M | -$26.1M | — |
| Gross margin | 69.5% | 64.8% | 62.3% | 57.1% | — |
| Gross profit | $913M | $777M | $623M | $492M | — |
| Operating income | $327M | $203M | $128M | $37.7M | — |
Headlines — positive tone
• [OK · fundamentals] HealthEquity Inc (HQY) (Q2 2027) Earnings Call Highlights: Record Revenue and Margin Expansion ...
News
2026-10-07 · Reasons to Hold HealthEquity Stock in Your Portfolio for Now
2026-09-30 · HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
2026-09-04 · Reasons to Hold HealthEquity Stock in Your Portfolio for Now
2026-09-02 · HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
2026-09-01 · HealthEquity’s (HQY) Health Savings Engine Hits A New Gear
2026-09-01 · HealthEquity (HQY) Q2 2027 Earnings Call Transcript
2026-08-31 · Deutsche Bank Adjusts HealthEquity Price Target to $142 From $135, Maintains Buy Rating
2026-08-30 · Why HealthEquity Stock Sank This Week
2026-08-28 · HealthEquity (HQY) Could Be 19% Undervalued On Raised Full Year Guidance
2026-08-28 · HealthEquity Catalysts Intact After Q2 Beat, RBC Says
2026-08-28 · HealthEquity (HQY) Stock May Be 48% Undervalued On Cash Flow
2026-08-27 · Healthequity Insider Sold Shares Worth $798,373, According to a Recent SEC Filing
Price (daily)
Full chart · RSI · MACD · patterns